Results 91 to 100 of about 5,894 (144)

Identification of IPF specific genes expressed by lung tissue-derived fibroblasts using next generation sequencing. [PDF]

open access: yesSarcoidosis Vasc Diffuse Lung Dis
Seo EJ   +8 more
europepmc   +1 more source

C/EBP-β-regulated complement hyperactivation in spleen of SFTSV-infected mice: A clue to targeted complement therapy. [PDF]

open access: yesPLoS Pathog
Liu Y   +12 more
europepmc   +1 more source

Translational immunothrombosis in autoimmune Heparin-Induced thrombocytopenia: targeting the FcγRIIa-Syk-BTK and complement pathways. [PDF]

open access: yesClin Exp Med
Ahmadinia M   +5 more
europepmc   +1 more source

Complement role in kidney disease: a comprehensive review and therapeutic innovations. [PDF]

open access: yesBMC Nephrol
Cortez Ferreira B   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Inhibition of bFGF activity by complement C1s: covalent binding of C1s with bFGF

Cell Biochemistry and Function, 1998
The first complement component C1s formed large aggregates with bFGF when bFGF and C1s were incubated at 37 degrees C overnight. Under non-reducing conditions, a part of the aggregates did not penetrate into 5% polyacrylamide gel in the presence of SDS, and the rest penetrated into 5% gel but not into 12% gel.
K Kaji, H Sakiyama
exaly   +3 more sources

Paramyosin inhibits complement C1

The Journal of Immunology, 1992
Abstract We report here the results of studies showing that inhibition of C is a property of several invertebrate paramyosins. Paramyosins from Taenia solium, Schistosoma mansoni, and the mussel Mytilus edulis bind polymeric collagen and can be isolated from crude extracts of tissues by collagen affinity.
J P, Laclette   +7 more
openaire   +2 more sources

Complement C1-inhibitor expression in Alzheimer's disease

Acta Neuropathologica, 1998
In situ and in vitro studies suggest that activation of locally produced complement factors may act as a mediator between amyloid deposits and neurodegenerative changes seen in Alzheimer's disease (AD). C1-esterase inhibitor (C1-Inh), which regulates activation of C1 of the complement classical pathway, can be detected immunohistochemically in its ...
Veerhuis, R.   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy